The peer-authored management source for clinical lab professionals since 1969.
Continuing Education
Diagnostics
Disease
Management
Molecular
Sections
Continuing Education
Diagnostics
Disease
Management
Molecular
Information Technology
Online Exclusives
Special
Magazine
Newsletter
Webinars
White Papers
eBooks
Clinical Laboratory Reference
Videos
Contact
About Us
Magazine Subscription
Newsletter Subscription
Advertise
Contact Us
Affiliated Brands
HEALTHCARE PURCHASING NEWS
HEALTHCARE INNOVATION
Follow us on
https://www.facebook.com/MLOMedicalLaboratoryObserver
https://www.linkedin.com/company/medical-laboratory-observer
https://twitter.com/MedicalLabMLO
Home
Adulterants and drugs-of-abuse testing: an update
MLO Staff
Feb. 1, 2008
About the Author
MLO Staff
Sign up for Medical Laboratory Observer eNewsletters
SIGN UP
Related
Peter Bach, MD, Chief Medical Officer of DELFI Diagnostics discusses blood test for lung cancer detection
The utility of polymerase chain reaction testing for urinary tract infections
Sponsored
A Fresh Look at Temperature Tracking Accuracy
Sponsored
A Cancer Center’s Path to Smarter Monitoring
Trending
Next-generation diabetes monitoring: Orange Biomed’s microfluidic breakthrough
Beyond the bench: How artificial intelligence is redefining respiratory pathogen diagnostics in the clinical laboratory
Product Focus - Diabetes
Recommended
A Cancer Center’s Path to Smarter Monitoring
A Fresh Look at Temperature Tracking Accuracy
Streamline Temperature Control in Your Lab
Load More Content
